233 related articles for article (PubMed ID: 23072344)
1. Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons.
Lakey W; Yang LY; Yancy W; Chow SC; Hicks C
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):435-40. PubMed ID: 23072344
[TBL] [Abstract][Full Text] [Related]
2. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada.
Koethe JR; Jenkins CA; Lau B; Shepherd BE; Justice AC; Tate JP; Buchacz K; Napravnik S; Mayor AM; Horberg MA; Blashill AJ; Willig A; Wester CW; Silverberg MJ; Gill J; Thorne JE; Klein M; Eron JJ; Kitahata MM; Sterling TR; Moore RD;
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):50-8. PubMed ID: 26352511
[TBL] [Abstract][Full Text] [Related]
3. HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy.
Bares SH; Smeaton LM; Xu A; Godfrey C; McComsey GA
J Womens Health (Larchmt); 2018 Sep; 27(9):1162-1169. PubMed ID: 29608129
[TBL] [Abstract][Full Text] [Related]
4. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.
Koethe JR; Jenkins CA; Shepherd BE; Stinnette SE; Sterling TR
Clin Infect Dis; 2011 Nov; 53(9):952-60. PubMed ID: 21946189
[TBL] [Abstract][Full Text] [Related]
5. Safety of monitoring antiretroviral therapy response in HIV-1 infection using CD4+ T cell count at long-term intervals.
Vogler IH; Alfieri DF; Gianjacomo HDB; Almeida ERD; Reiche EMV
Cad Saude Publica; 2018 Oct; 34(10):e00009618. PubMed ID: 30365742
[TBL] [Abstract][Full Text] [Related]
6. Progression to overweight, obesity and associated factors after antiretroviral therapy initiation among Brazilian persons with HIV/AIDS.
Maia Leite LH; De Mattos Marinho Sampaio AB
Nutr Hosp; 2010; 25(4):635-40. PubMed ID: 20694301
[TBL] [Abstract][Full Text] [Related]
7. Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.
Bussmann H; Wester CW; Thomas A; Novitsky V; Okezie R; Muzenda T; Gaolathe T; Ndwapi N; Mawoko N; Widenfelt E; Moyo S; Musonda R; Mine M; Makhema J; Moffat H; Essex M; Degruttola V; Marlink RG
J Acquir Immune Defic Syndr; 2009 May; 51(1):37-46. PubMed ID: 19282782
[TBL] [Abstract][Full Text] [Related]
8. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
9. HIV infection and obesity: where did all the wasting go?
Tate T; Willig AL; Willig JH; Raper JL; Moneyham L; Kempf MC; Saag MS; Mugavero MJ
Antivir Ther; 2012; 17(7):1281-9. PubMed ID: 22951353
[TBL] [Abstract][Full Text] [Related]
10. Elevated Levels of Estradiol in Human Immunodeficiency Virus-Infected Pregnant Women on Protease Inhibitor-Based Regimens.
Balogun KA; Guzman Lenis MS; Papp E; Loutfy M; Yudin MH; MacGillivray J; Walmsley SL; Silverman M; Serghides L
Clin Infect Dis; 2018 Jan; 66(3):420-427. PubMed ID: 29020282
[TBL] [Abstract][Full Text] [Related]
11. Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir.
Calza L; Colangeli V; Borderi M; Bon I; Borioni A; Volpato F; Re MC; Viale P
Infection; 2020 Apr; 48(2):213-221. PubMed ID: 31713814
[TBL] [Abstract][Full Text] [Related]
12. When and why to start antiretroviral therapy?
Gatell JM
J Antimicrob Chemother; 2010 Mar; 65(3):383-5. PubMed ID: 20071369
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
[TBL] [Abstract][Full Text] [Related]
14. Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.
Karo B; Krause G; Castell S; Kollan C; Hamouda O; Haas W;
BMC Infect Dis; 2017 Jul; 17(1):517. PubMed ID: 28743248
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated With Being Overweight and Obesity in People Living With Human Immunodeficiency Virus on Antiretroviral Therapy: Socioclinical, Inflammation, and Metabolic Markers.
Goupil de Bouillé J; Vigouroux C; Plessis L; Ghislain M; Teglas JP; Boufassa F; Goujard C; Vignes D; Bouchaud O; Salmon D; Meyer L; Abgrall S;
J Infect Dis; 2021 Nov; 224(9):1570-1580. PubMed ID: 33740044
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.
Guehi C; Badjé A; Gabillard D; Ouattara E; Koulé SO; Moh R; Ekouevi D; Ahibo H; N'Takpé JB; Menan GK; Deschamps N; Lecarrou J; Eholié S; Anglaret X; Danel C
AIDS Res Ther; 2016; 13():12. PubMed ID: 26925155
[TBL] [Abstract][Full Text] [Related]
17. Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US.
Buchacz K; Baker RK; Palella FJ; Shaw L; Patel P; Lichtenstein KA; Chmiel JS; Vellozzi C; Debes R; Henry K; Overton ET; Bush TJ; Tedaldi E; Carpenter C; Mayer KH; Brooks JT;
Antivir Ther; 2013; 18(1):65-75. PubMed ID: 23111762
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of combination antiretroviral therapy in HIV type 1-infected patients treated in Curaçao compared with Antillean, Surinam, and Dutch HIV type 1-infected patients treated in The Netherlands.
Hermanides HS; Gras L; Winkel CN; Gerstenbluth I; van Sighem A; de Wolf F; Duits AJ
AIDS Res Hum Retroviruses; 2011 Jun; 27(6):605-12. PubMed ID: 21155654
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study.
Boodram B; Plankey MW; Cox C; Tien PC; Cohen MH; Anastos K; Karim R; Hyman C; Hershow RC
AIDS Patient Care STDS; 2009 Dec; 23(12):1009-16. PubMed ID: 19909168
[TBL] [Abstract][Full Text] [Related]
20. Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients.
Tedaldi EM; Brooks JT; Weidle PJ; Richardson JT; Baker RK; Buchacz K; Moorman AC; Wood KC; Holmberg SD;
J Acquir Immune Defic Syndr; 2006 Sep; 43(1):35-41. PubMed ID: 16885779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
